Next Article in Journal
Preparation, In Vitro Characterization, and Cytotoxicity Evaluation of Polymeric pH-Responsive Hydrogels for Controlled Drug Release
Next Article in Special Issue
Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain
Previous Article in Journal
Lactoferrin-Conjugated Nanoparticles as New Antivirals
Previous Article in Special Issue
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1863; https://doi.org/10.3390/pharmaceutics14091863
Action Date Notes Link
article xml file uploaded 3 September 2022 14:00 CEST Original file -
article xml uploaded. 3 September 2022 14:00 CEST Update -
article pdf uploaded. 3 September 2022 14:00 CEST Version of Record -
article supplementary file uploaded. 3 September 2022 14:00 CEST - https://www.mdpi.com/1999-4923/14/9/1863#supplementary
article html file updated 3 September 2022 14:01 CEST Original file -
article xml file uploaded 3 September 2022 14:16 CEST Update -
article xml uploaded. 3 September 2022 14:16 CEST Update https://www.mdpi.com/1999-4923/14/9/1863/xml
article pdf uploaded. 3 September 2022 14:16 CEST Updated version of record https://www.mdpi.com/1999-4923/14/9/1863/pdf
article html file updated 3 September 2022 14:18 CEST Update -
article html file updated 28 February 2023 12:13 CET Update https://www.mdpi.com/1999-4923/14/9/1863/html
Back to TopTop